Clinical Significance of Marginal Acute Inflammation for Stage II Colon Cancer
NCT06135558 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1167
Last updated 2023-11-18
Summary
Marginal acute inflammation would make reporting the serosal involvement of tumors controversial. We aimed to investigate the clinical significance and explore the prognostic value of MAI for stage II localized colon cancer.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
MAI detection
to detect the presence of marginal acute inflammation
Sponsors & Collaborators
-
Sun Yat-sen University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-01-30
- Primary Completion
- 2022-12-30
- Completion
- 2023-10-30
More Related Trials
-
Detection of CTCs in Stage III Rectal Cancer Patients Undergoing Neoadjuvant Therapy
NCT02554448 ·Status: UNKNOWN ·Phase: NA
-
The Value of MRI in Assessing the Status of Retroperitoneal Resection Margin in Colon Cancer
NCT05859581 ·Status: UNKNOWN ·Phase: NA
-
Oncological Impact of Lateral Nodes in Rectal Cancer
NCT05592873 ·Status: COMPLETED
-
Impact of Body Mass Index and Lipid Metabolism on Anti-PD-1 Immunotherapy Outcomes in Colorectal Cancer
NCT07012174 ·Status: COMPLETED
-
CGA Guided Ultrafractionated RT and First-line Systemic Treatment in Elderly or Frail Patients with MCRC
NCT06665087 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Constructing a Multimodal Imaging System to Predict the Risk of Heterochronous Metastasis of Rectal Cancer
NCT06293612 ·Status: COMPLETED
-
The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey
NCT01549067 ·Status: UNKNOWN
-
Early Lymph Node Metastasis in T1/2 Stage Colorectal Cancer: Molecular and Clinical Insights
NCT06130644 ·Status: COMPLETED
-
Sentinel Lymph Node Biopsy in Rectal Cancer
NCT05830890 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
High-activity Natural Killer Immunotherapy for Small Metastases of Colorectal Cancer
NCT03008499 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The CSTME Associates With the Prognosis of Stage II and III Colorectal Cancer
NCT05420415 ·Status: COMPLETED
-
Borderline of CME/D3 Dissection for Local Advanced Right-sided Colon Cancer
NCT06709144 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
The Application Value of Spectral CT in the Accurate Staging of Colorectal Cancer
NCT06977373 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Application of Multimodal MRI in Histological Grading and Prognostic Assessment of Rectal Cancer
NCT07269912 ·Status: NOT_YET_RECRUITING
-
Evaluation of Inflammatory Markers in LARC Patients
NCT05893667 ·Status: COMPLETED
-
Chemoradiation and Endothelial Progenitor Cells in Colorectal Cancer
NCT00325871 ·Status: COMPLETED
-
Surgery Following Immune Checkpoint Inhibitions for Controlled Disease in Recurrent or Metastatic dMMR/MSI-H Colorectal Cancer
NCT06717763 ·Status: COMPLETED
-
Association Between Tumor Size and Prognosis in Patients With Small Bowel adenocarcinoma-a SEER-based Study
NCT06087887 ·Status: COMPLETED
-
Chemotherapy Combined With High-dose Radiotherapy for Low Rectal Cancer Using MR Guided Linear Accelerator
NCT05338866 ·Status: ENROLLING_BY_INVITATION
-
MRD-Guided Surveillance in Operable Colon Adenocarcinoma (I-III)(SURVEILLANCE-I)
NCT06879873 ·Status: NOT_YET_RECRUITING
-
Tumor Budding in Patients With Colorectal Cancer Under Different MMR Status
NCT05610592 ·Status: COMPLETED
-
Explore Biomarkers Associated With Prognosis of Recurrent and Metastatic CRC After Surgery by Multi-omics Methods
NCT05501353 ·Status: RECRUITING
-
Envafolimab as Neoadjuvant Immuntherapy in Resectable Local Advanced dMMR/MSI-H Colorectal Cancer
NCT05371197 ·Status: UNKNOWN ·Phase: PHASE2
-
Significance of Cortactin Expression in Colorectal Adenocarcinomas
NCT05225870 ·Status: COMPLETED ·Phase: NA
-
The Implication of ctDNA in the Recurrence Surveillance of Stage II and III Colorectal Cancer
NCT03416478 ·Status: UNKNOWN